Can Semaglutide Cause Kidney Stones?

    By Trimi Medical Team5 min read

    Semaglutide does not directly cause kidney stones. Kidney stones are not listed as a side effect in the prescribing information for semaglutide (Ozempic, Wegovy). However, the reduced fluid intake, nausea, and occasional vomiting that occur during GLP-1 treatment can lead to dehydration, which is a well-established risk factor for kidney stone formation.

    Medical Disclaimer: This article is for informational purposes only. If you experience severe flank pain, blood in urine, or symptoms of kidney stones, seek medical attention promptly.

    The Indirect Connection: Dehydration

    The primary link between semaglutide and kidney stone risk is dehydration. Semaglutide can contribute to dehydration in several ways:

    • Reduced appetite leads to less fluid intake: Many patients forget to drink when they are not eating, since meals are often when people consume a significant portion of their daily fluids.
    • Nausea and vomiting: GI side effects, particularly during dose titration, can cause fluid loss.
    • Diarrhea: Some patients experience diarrhea, leading to additional fluid and electrolyte loss.

    Concentrated urine from dehydration allows minerals like calcium, oxalate, and uric acid to crystallize, forming kidney stones. This risk exists regardless of the cause of dehydration.

    Semaglutide and Kidney Health: The Bigger Picture

    Emerging research actually suggests semaglutide may be beneficial for kidney health in several ways:

    • Weight loss reduces kidney disease risk: Obesity is a major risk factor for chronic kidney disease. The weight loss achieved with semaglutide may be protective.
    • Blood sugar improvement: Better glycemic control reduces diabetic nephropathy progression.
    • Blood pressure reduction: Semaglutide-associated weight loss often lowers blood pressure, which benefits kidney function.
    • Direct renal effects: Some studies suggest GLP-1 receptor agonists may have direct anti-inflammatory and anti-fibrotic effects in the kidneys, though this research is still evolving.

    Prevention Strategies

    • Drink at least 64 oz (8 cups) of water daily, even if you don't feel thirsty.
    • Set hydration reminders on your phone, especially during early treatment when appetite is most suppressed.
    • Monitor urine color: Pale yellow indicates adequate hydration. Dark yellow or amber signals dehydration.
    • Replace electrolytes if you experience vomiting or diarrhea.
    • Limit high-oxalate foods if you have a history of calcium oxalate stones (spinach, rhubarb, nuts, chocolate).
    • Report persistent vomiting to your provider, as this may warrant dose adjustment.

    Frequently Asked Questions

    Can semaglutide cause kidney stones?

    Semaglutide does not directly cause kidney stones. However, dehydration from reduced fluid intake, nausea, or vomiting during treatment can increase kidney stone risk indirectly. Staying well hydrated is the best prevention.

    Is semaglutide safe for kidneys?

    Yes, semaglutide is generally safe for kidneys and may even have protective effects through weight loss and improved metabolic health. However, severe dehydration from vomiting or inadequate fluid intake can cause acute kidney injury in rare cases.

    How much water should you drink on semaglutide?

    Aim for at least 64 ounces (8 cups) of water daily, and more if you exercise, live in a hot climate, or experience GI side effects. Monitor your urine color as a practical hydration indicator.

    For monitored GLP-1 treatment with hydration and nutrition guidance, explore Trimi's treatment programs.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading